Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo
Open Access
- 8 March 2019
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 1-13
Abstract
The Na+/H+ exchanger (NHE1) plays a crucial role in cancer cell proliferation and metastasis. However, the mechanism underlying chemotherapeutic resistance in cancer cells has not been completely elucidated. The NHE1 inhibitor cariporide has been demonstrated to inhibit human cancer cell lines. The goal of this study was to provide new sights into improved cancer cell chemosensitivity mediated by cariporide with activation of the apoptosis pathway. The NHE1 expression levels were first evaluated using the online database Oncomine and were determined by RT-PCR and western blot in vitro and in vivo. Cell proliferation was assessed In vitro through a CCK-8 assay, and apoptosis was analyzed by flow cytometry. An in vivo analysis was performed in BALB/c nude mice, which were intraperitoneally injected with MCF-7/ADR cells. NHE1 levels were significantly higher in breast cancer tissue than adjacent tissue, as well as in resistant cancer cells compared to sensitive cells. Cariporide induced the apoptosis of MCF-7/ADR cells and was associated with the intracellular accumulation of doxorubicin and G0/G1 cell cycle arrest. Moreover, cariporide decreased MDR1 expression and activated cleaved caspase-3 and caspase-9, promoting caspase-independent apoptosis in vitro. In vivo, cariporide significantly improved doxorubicin sensitivity in a xenograft model, enhancing tumor growth attenuation and diminishing tumor volume. Our results demonstrate that cariporide significantly facilitates the sensitivity of breast cancer to doxorubicin both in vitro and in vivo. This finding suggests that NHE1 may be a novel adjuvant therapeutic candidate for the treatment of resistant breast cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81672913)
- Social Development Project of Jiangsu (BE2018693)
- Natural Science Foundation of Jiangsu Province (BK20171311)
- Social Development of Zhenjiang (SH2017016)
- Medical Development of Jiangsu University (JLY20160022)
This publication has 55 references indexed in Scilit:
- Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosisBMC Cell Biology, 2013
- Blocking the Na+/H+ exchanger 1 with cariporide (HOE642) reduces the hypoxia-induced invasion of human tongue squamous cell carcinomaInternational Journal of Oral and Maxillofacial Surgery, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinomaJournal of Experimental & Clinical Cancer Research, 2012
- Dysregulated pH: a perfect storm for cancer progressionNature Reviews Cancer, 2011
- IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancerNature Reviews Cancer, 2010
- The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancerJournal of Experimental & Clinical Cancer Research, 2009
- Caspases and Kinases in a Death GripCell, 2009
- Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer CellsCancer Research, 2007
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002